Vericel Announces Appointment of Lisa Wright to Board of Directors
CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the appointment of Lisa Wright to its Board of Directors, effective immediately.
- CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the appointment of Lisa Wright to its Board of Directors, effective immediately.
- With the appointment of Ms. Wright, Vericels Board is now comprised of eight directors, seven of whom are independent.
- We are delighted to welcome Lisa to the Vericel Board of Directors, said Nick Colangelo, President and Chief Executive Officer of Vericel.
- Lisas appointment reflects Vericels commitment to ensuring that we have a broad set of skills and perspectives on the Board, said Robert L. Zerbe, M.D., Chairman of the Vericel Board of Directors.